Recurrence: all 3,523 studies
Page 4 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHLRecruitingNCT07059741Not applicable
- Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional ImmunotherapiesRecruitingNCT07051850
- A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical CancerRecruitingNCT07051486Phase 2
- Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer SurvivorsRecruitingNCT07030686
- Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral HemorrhageRecruitingNCT07026994Phase 2
- SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid TumorsRecruitingNCT07022002Phase 2
- Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple MyelomaRecruitingNCT07018050Phase 2
- A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid TumorsRecruitingNCT07015697Phase 1
- Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07014449Phase 1
- The Efficacy and Safety of Deucravacitinib in Takayasu's ArteritisNot yet recruitingNCT07013838Phase 4
- A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell LymphomaRecruitingNCT07011056Phase 3
- Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387RecruitingNCT07010159Phase 2/3
- Transvaginal Diverticulum Wall Filling and Coverage Technique for Treating Female Circumferential Urethral DiverticulumEnrolling by invitationNCT07006753Not applicable
- Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary InfiltrationRecruitingNCT07003568Phase 1
- Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary InfiltrationRecruitingNCT07003555Phase 1
- Personalized Neoantigen Peptide Vaccines for Solid TumorsRecruitingNCT07002203Phase 1/2
- The CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesRecruitingNCT07002112Phase 1
- Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous TransplantationRecruitingNCT07001540Phase 2
- A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple MyelomaRecruitingNCT06999031Early Phase 1
- Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell LymphomaRecruitingNCT06996132Phase 2
- Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast CancerRecruitingNCT06993506
- Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell LymphomaRecruitingNCT06987916Phase 1/2
- RVU120 Rollover StudyEnrolling by invitationNCT06987058Phase 2
- CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic DifferentiationNot yet recruitingNCT06986434Early Phase 1
- Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized TrialNot yet recruitingNCT06982690Not applicable
- A Study of Linperlisib (YY-20394) in Combination With Rituximab in Patients With Relapsed/Refractory Indolent NHLNot yet recruitingNCT06981988Phase 1/2
- Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell MalignanciesRecruitingNCT06980116Phase 1
- Secondary Prevention of Clostridioides Difficile Using VancomycinRecruitingNCT06979609Phase 2/3
- Predicting Psychotic Relapse Using Speech-Based Early DetectionRecruitingNCT06978894
- A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaRecruitingNCT06976190Phase 3
- High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous SeedRecruitingNCT06972602Early Phase 1
- Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain AmyloidosisRecruitingNCT06971380Phase 2
- A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.Not yet recruitingNCT06970496Phase 1
- A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCLRecruitingNCT06966154Phase 1/2
- Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell LymphomaRecruitingNCT06961669Not applicable
- Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use DisorderRecruitingNCT06949423Not applicable
- A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.Not yet recruitingNCT06948461Phase 2
- Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal CancerRecruitingNCT06934018Not applicable
- Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab TreatmentEnrolling by invitationNCT06931613Phase 2
- A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.RecruitingNCT06927466Phase 1
- Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic SyndromesRecruitingNCT06923488Phase 1/2
- Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung CancerRecruitingNCT06922539Phase 1
- Stabilization of the Shoulder Joint Using a Latarjet-like Procedure.Enrolling by invitationNCT06920654
- Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell LymphomaRecruitingNCT06919939Phase 2
- Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy FailureRecruitingNCT06918912Phase 2
- QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial CancerRecruitingNCT06917092Phase 2
- Tamoxifen for Advanced Solid Pseudopapillary Tumor of the PancreasRecruitingNCT06914674Phase 2
- Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma RecurrenceRecruitingNCT06911736Not applicable
- Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell LymphomaRecruitingNCT06909877Phase 1/2
- Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer PatientsNot yet recruitingNCT06908772Phase 2/3
- JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal CancerNot yet recruitingNCT06892431Phase 2
- Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant TherapyNot yet recruitingNCT06889402
- JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament ReconstructionRecruitingNCT06883396
- Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple MyelomaNot yet recruitingNCT06880601Phase 2
- A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid TumorsRecruitingNCT06880549Phase 1
- A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AMLRecruitingNCT06879847Not applicable
- Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+RecruitingNCT06874530
- Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid TumorsAvailableNCT06872489
- TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CancerRecruitingNCT06868433Phase 1
- Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALLRecruitingNCT06863259Phase 1
- P : Ingrown Toenail Patient I : Bird Flap Surgery C : Noel Winograd Method O : Recurrence, Complications, Functional Outcome, Pain,Not yet recruitingNCT06862232Not applicable
- SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical CancerRecruitingNCT06859775Phase 1/2
- A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCLRecruitingNCT06855823Phase 1/2
- A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCLRecruitingNCT06854653Phase 2
- Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDSRecruitingNCT06846606Phase 1
- Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute LeukemiaRecruitingNCT06845592Not applicable
- Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin LymphomaNot yet recruitingNCT06845241Phase 1/2
- Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHLRecruitingNCT06838832Phase 1/2
- Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic TumorsNot yet recruitingNCT06837389Early Phase 1
- CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and LymphomaRecruitingNCT06834529Phase 1/2
- ELISA in Relapsed/Refractory MMRecruitingNCT06832865Phase 2
- Mindfulness-Based Cognitive Therapy (MBCT) for the Prevention of Depression Relapse or Recurrence Using VideoconferenceRecruitingNCT06832605Not applicable
- Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early RelapseRecruitingNCT06827860Phase 2
- Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System LymphomaEnrolling by invitationNCT06827782Phase 1
- Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell TherapyNot yet recruitingNCT06825845
- A Study to Prevent Infantile Spasms RelapseRecruitingNCT06819670Phase 2
- Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or AdolescentsRecruitingNCT06816771Phase 2
- Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.RecruitingNCT06812104Phase 1
- Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)RecruitingNCT06810778Phase 1/2
- Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHLRecruitingNCT06806033Phase 2
- Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)RecruitingNCT06802315Phase 2
- Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent GliomaRecruitingNCT06801730Phase 2
- Immunotherapy in LymphomaRecruitingNCT06796517
- Surveillance Intervals After Piecemeal Resection of Non-pedunculated Colorectal Lesions ≥20mmNot yet recruitingNCT06791616Not applicable
- Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)RecruitingNCT06788964Phase 2
- Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory LymphomaNot yet recruitingNCT06788600
- Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AMLRecruitingNCT06786533Phase 1
- Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder CancerRecruitingNCT06781879Phase 4
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaRecruitingNCT06769698Phase 2
- BV in the Treatment of Relapsed/refractory Hodgkin LymphomaNot yet recruitingNCT06761911Phase 4
- Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.Not yet recruitingNCT06754540Phase 2
- QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial CancerNot yet recruitingNCT06751277Phase 2
- Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory NeuroblastomaRecruitingNCT06751134Phase 1
- Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II TrialNot yet recruitingNCT06750952Phase 2
- Predictors of Relapse in Major Depressive Disorder (PERFORM-D)RecruitingNCT06746155
- UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell MalignanciesRecruitingNCT06743503Phase 1
- VHAG in Treating R/R T-ALL/LBLRecruitingNCT06742463Phase 2
- A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade MeningiomaNot yet recruitingNCT06739213Phase 2
- Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AMLRecruitingNCT06737523Phase 1
- NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSLRecruitingNCT06737250Phase 2